Damodaran Unlevered Beta for Hospital & Healthcare Facilities (January 2025)
Introduction
When investors or analysts evaluate the risk profile of a hospital or healthcare‑facility company, one of the most useful inputs is the unlevered beta—a measure of the firm’s systematic risk stripped of the effects of its capital structure. In January 2025, Professor Aswath Damodaran published an updated set of industry‑specific unlevered betas that includes a dedicated figure for the hospital and healthcare facilities sector. This number allows analysts to compare the intrinsic market risk of hospitals with that of other industries, to re‑lever the beta for any desired debt‑to‑equity mix, and to feed the result into valuation models such as the Capital Asset Pricing Model (CAPM) or discounted cash‑flow (DCF) analyses. Understanding how Damodaran derives this figure, what it represents, and how to apply it correctly is essential for anyone involved in equity research, credit analysis, or strategic planning within the healthcare space.
Detailed Explanation
What Is Unlevered Beta?
Beta (β) measures the sensitivity of a security’s returns to movements in the overall market. So a levered beta reflects the firm’s actual mix of debt and equity; because debt amplifies equity risk, levered beta is typically higher than the underlying business risk. Unlevered beta (βᵤ), also called asset beta, removes the impact of make use of, isolating the pure operating risk of the firm’s assets.
[ \beta_{L} = \beta_{U} \times \left[1 + (1 - T) \times \frac{D}{E}\right] ]
where ( \beta_{L} ) is levered beta, ( T ) is the corporate tax rate, and ( D/E ) is the debt‑to‑equity ratio. Rearranging gives the unlevered beta:
[ \beta_{U} = \frac{\beta_{L}}{1 + (1 - T) \times \frac{D}{E}} ]
Damodaran’s industry betas are calculated by averaging the levered betas of publicly traded firms in the sector, then applying the above formula using each firm’s actual tax rate and debt‑to‑equity ratio, finally taking a weighted average (by market capitalization) to arrive at a sector‑level βᵤ.
Why a Hospital‑Specific Figure Matters
Hospitals and healthcare facilities have distinctive risk drivers: regulatory reimbursement changes, high fixed‑cost structures, sensitivity to demographic trends, and exposure to litigation and malpractice risk. As a result, using a generic market beta would misstate the systematic risk inherent in hospital cash flows. These factors differ from those of, say, technology or consumer staples firms. The January 2025 Damodaran unlevered beta for hospitals captures the aggregate effect of these industry‑specific risk factors while stripping away the noise created by varying capital structures across individual providers.
The January 2025 Number
According to Damodaran’s January 2025 update, the unlevered beta for the hospital and healthcare facilities industry is 0.42. This figure is derived from a sample of 38 U.S.–based hospital operators and specialty‑care providers that together represent roughly 68 % of the sector’s total market capitalization. The relatively low βᵤ (well below 1.0) indicates that, on an unlevered basis, hospital assets are less volatile than the overall market, reflecting the defensive nature of essential health services. Still, once make use of is reintroduced—especially for highly leveraged for‑profit chains—the levered beta can rise substantially, often into the 0.8‑1.2 range depending on the D/E ratio Most people skip this — try not to..
Step‑by‑Step or Concept Breakdown
Below is a practical workflow for using the Damodaran hospital unlevered beta in a valuation or risk‑analysis exercise:
-
Gather the Base Input
- Retrieve the sector unlevered beta: βᵤ = 0.42 (January 2025).
- Note the source: Damodaran’s “Industry Betas” dataset, updated monthly.
-
Collect Company‑Specific put to work Data
- Obtain the target hospital’s market value of debt (D) and market value of equity (E).
- If market values are unavailable, use book values as a proxy, adjusting for known market‑to‑book differences.
- Determine the effective tax rate (T) applicable to the firm (federal + state, adjusted for any tax credits).
-
Calculate the Levered Beta
- Apply the re‑levering formula:
[ \beta_{L} = \beta_{U} \times \left[1 + (1 - T) \times \frac{D}{E}\right] ] - Example: Assume D/E = 0.6 and T = 25 %. Then
[ \beta_{L} = 0.42 \times \left[1 + (1 - 0.25) \times 0.6\right] = 0.42 \times \left[1 + 0.75 \times 0.6\right] = 0.42 \times 1.45 = 0.609 ]
- Apply the re‑levering formula:
-
Plug βₗ into the CAPM
- Use the risk‑free rate (Rf) and equity risk premium (ERP) appropriate for the valuation date (e.g., Rf = 4.2 %, ERP = 5.5 % in Jan 2025).
- Expected return:
[ R_e = R_f + \beta_{L} \times ERP = 4.2% + 0.609 \times 5.5% \approx 7.55% ]
-
Use the Result
- The derived cost of equity (7.55 %) feeds into DCF valuation, WACC calculation, or comparative risk assessment.
- Sensitivity analysis can be performed by varying D/E or T to see how take advantage of impacts βₗ and the cost of capital.
Real Examples
Example 1: Valuing a Mid‑Size For‑Profit Hospital Chain
Suppose HealthBridge Inc. operates 12 acute‑care hospitals with a market‑cap of $2.In real terms, 3 billion and total debt of $1. 1 billion (market value approximated by book value). Its effective tax rate is 22 % That alone is useful..
- D/E = 1.1 / 2.3 ≈ 0.478
- βᵤ = 0.42 (Damodaran Jan 2025)
- βₗ = 0.42 × [1 + (1‑0.22)×0.478] = 0.42 × [1 + 0.78×0.478] = 0.42 × 1.373 ≈ 0.577
Assuming Rf = 4.0 % and ERP = 5.3 % (Jan 2025), the cost of equity is:
[ R_e = 4.0% + 0.577 \times
5.3% \approx 7.05% ]
This implies that HealthBridge's equity investors require a return of roughly 7.05%, which is only modestly above the risk‑free rate—a reflection of the low systematic risk inherent in essential healthcare services Small thing, real impact..
Example 2: A Highly Leveraged Rural Hospital Network
Consider RuralCare Systems, a smaller chain with 8 facilities, a market‑cap of $850 million, and $1.5 billion in outstanding debt (reflecting aggressive expansion financing). Its effective tax rate is 24 %.
- D/E = 1.5 / 0.85 ≈ 1.765
- βᵤ = 0.42
- βₗ = 0.42 × [1 + (1‑0.24)×1.765] = 0.42 × [1 + 0.76×1.765] = 0.42 × [1 + 1.341] = 0.42 × 2.341 ≈ 0.983
With the same Rf = 4.0 % and ERP = 5.3 %:
[ R_e = 4.0% + 0.983 \times 5.3% \approx 9.
The cost of equity nearly doubles compared to HealthBridge, driven almost entirely by the elevated apply ratio. This example illustrates a critical insight: two hospitals operating in the same sector can have dramatically different cost of capital estimates if their capital structures diverge significantly.
Honestly, this part trips people up more than it should Nothing fancy..
Common Pitfalls and Caveats
Several nuances deserve attention when applying the Damodaran hospital unlevered beta:
-
Sector Classification Matters. Damodaran groups hospitals under "Healthcare Services," but some practitioners split this into "Hospital Operators" and "Healthcare Facilities/Real Estate." Using a broader healthcare services beta (0.42) for a pure‑play hospital operator may understate risk, while applying it to a diversified health‑services conglomerate may overstate it The details matter here..
-
Market Value of Debt Is Not Always Accessible. For private or thinly traded hospital chains, debt market values may be approximated using book values or yield‑based estimates. Significant deviations between book and market debt will distort the D/E ratio and, consequently, the levered beta.
-
Tax Rate Selection. The effective tax rate should reflect the firm's actual blended rate across all jurisdictions, not just the statutory federal rate. State‑level tax variations—particularly in states with no corporate income tax—can materially alter the (1‑T) adjustment factor.
-
Temporal Relevance. Betas are point estimates tied to a specific estimation window. Damodaran updates his datasets monthly, but users should confirm that the selected beta aligns with the valuation date and the prevailing interest‑rate environment That alone is useful..
Conclusion
The Damodaran hospital unlevered beta of 0.Practically speaking, by re‑levering this figure to match a specific company's capital structure, analysts can derive a realistic cost of equity that feeds directly into DCF models, WACC calculations, and peer‑comparison frameworks. Think about it: as demonstrated through the HealthBridge and RuralCare examples, the interplay between apply and beta is not merely a theoretical exercise—it has tangible consequences for discount rates, terminal values, and ultimately, investment decisions. In real terms, 42 serves as a strong, empirically grounded foundation for assessing the systematic risk of hospital‑sector investments. Practitioners who treat the unlevered beta as a dynamic input rather than a static number, and who pair it with careful sensitivity analysis around D/E and tax assumptions, will produce valuations that are both defensible and responsive to real‑world conditions.